FDA.reportPublic FDA data

MS Contin 30 MG Extended Release Oral Tablet

RxCUI
892660
RxNorm name
MS Contin 30 MG Extended Release Oral Tablet
Display name
MS Contin 30 MG Extended Release Oral Tablet
Full name
MS Contin 30 MG Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MS ContinMORPHINE SULFATERhodes Pharmaceuticals LLCc354b3bf-86c0-4bb8-8b1f-be21649426982026-05-18Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 892660

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c354b3bf-86c0-4bb8-8b1f-be2164942698MS Contin 30 MG Extended Release Oral Tablet [PSN] · morphine sulfate 30 MG Extended Release Oral Tablet [MS Contin] [SBD] · MS 30 MG Extended Release Oral Tablet [MS Contin] [SY] · MS Contin 30 MG Extended Release Oral Tablet [SY]416These highlights do not include all the information needed to use MS CONTIN ® safely and effectively. See full prescribing information for MS CONTIN. MS CONTIN ® (morphine sulfate extended-release tablets), for oral use CII Initial U.S. Approval: 194120260504